Monster: Plans for Bang Become Clearer In Q2 Earnings Call
After completing its acquisition of Bang manufacturer Vital Pharmaceuticals’ assets on July 31 for $362 million, Monster co-CEO Rodney Sacks said during the company’s Q2 2023 earnings call yesterday that it is now preparing to fully integrate its former rival into the Monster Energy system.